{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:19:15Z","timestamp":1788581955124,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["221\/22"],"award-info":[{"award-number":["221\/22"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurot.2026.e00904","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:12:05Z","timestamp":1775866325000},"page":"e00904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nose-to-brain delivery of a SOD1-stabilizing small molecule ameliorates pathology in an ALS mouse model"],"prefix":"10.1016","volume":"23","author":[{"given":"Ranjithkumar","family":"Dhandapani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamchal","family":"Bakavayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Armoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bersudsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Shlifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Yehezkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tsitrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon C.","family":"Sintov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.neurot.2026.e00904_bib1","doi-asserted-by":"crossref","first-page":"13495","DOI":"10.1021\/ja1057136","article-title":"Folding catalysis by transient coordination of Zn2+ to the Cu ligands of the ALS-associated enzyme Cu\/Zn superoxide dismutase 1","volume":"132","author":"Leinartaite","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"51","key":"10.1016\/j.neurot.2026.e00904_bib2","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1021\/bi048831v","article-title":"Kinetic stability of Cu\/Zn superoxide dismutase is dependent on its metal ligands: implications for ALS","volume":"43","author":"Lynch","year":"2004","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-020-00209-y","article-title":"Does wild-type Cu\/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?","volume":"9","author":"Furukawa","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00904_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","article-title":"Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS","volume":"13","author":"Bosco","year":"2010","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib6","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1038\/s41598-018-31773-z","article-title":"Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis","volume":"8","author":"Par\u00e9","year":"2018","journal-title":"Sci Rep"},{"issue":"27","key":"10.1016\/j.neurot.2026.e00904_bib7","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1073\/pnas.0704307104","article-title":"Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS","volume":"104","author":"Banci","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00904_bib8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/molecules22091429","article-title":"The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase","volume":"22","author":"Sirangelo","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00904_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1073\/pnas.1516725113","article-title":"Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis","volume":"113","author":"Proctor","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.neurot.2026.e00904_bib10","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1073\/pnas.0809845106","article-title":"Structural and dynamic aspects related to oligomerization of Apo SOD1 and its mutants","volume":"106","author":"Banci","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00904_bib11","doi-asserted-by":"crossref","first-page":"E2546","DOI":"10.1073\/pnas.1721022115","article-title":"Effects of maturation on the conformational free-energy landscape of SOD1","volume":"115","author":"Culik","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2026.e00904_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fneur.2019.00527","article-title":"Structural properties and interaction partners of familial ALS-associated SOD1 mutants","volume":"10","author":"Huai","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e00904_bib13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fnmol.2019.00262","article-title":"Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis","volume":"12","author":"McAlary","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-015-1514-0","article-title":"Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways","volume":"131","author":"Ayers","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00904_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/acschemneuro.6b00227","article-title":"Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants","volume":"7","author":"Banerjee","year":"2016","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/acschemneuro.0c00524","article-title":"Exposure of \u03b26\/\u03b27-Loop in Zn\/Cu superoxide dismutase (SOD1) is coupled to metal loss and is transiently reversible during misfolding","volume":"12","author":"Bakavayev","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00904_bib17","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1093\/brain\/awad222","article-title":"Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis","volume":"146","author":"Bakavayev","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00904_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/ci6002202","article-title":"Use of amino acid composition to predict ligand-binding sites","volume":"47","author":"Soga","year":"2007","journal-title":"J Chem Inf Model"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00904_bib19","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.neurot.2026.e00904_bib20","doi-asserted-by":"crossref","first-page":"119725","DOI":"10.1016\/j.ijpharm.2020.119725","article-title":"AmyloLipid nanovesicles: a self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin","volume":"588","author":"Sintov","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.neurot.2026.e00904_bib21","article-title":"A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS","volume":"104","author":"Au - Hatzipetros","year":"2015","journal-title":"JoVE J"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep42323","article-title":"Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice","volume":"7","author":"Takeshita","year":"2017","journal-title":"Sci Rep"},{"issue":"45","key":"10.1016\/j.neurot.2026.e00904_bib23","doi-asserted-by":"crossref","first-page":"E6939","DOI":"10.1073\/pnas.1611418113","article-title":"Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy","volume":"113","author":"Sekhar","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2026.e00904_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07296","article-title":"Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways","volume":"4","author":"Sekhar","year":"2015","journal-title":"eLife"},{"issue":"43","key":"10.1016\/j.neurot.2026.e00904_bib25","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0907387106","article-title":"Transient structural distortion of metal-free Cu\/Zn superoxide dismutase triggers aberrant oligomerization","volume":"106","author":"Teilum","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-019-0341-5","article-title":"Wild-type Cu\/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis","volume":"14","author":"Tokuda","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"17","key":"10.1016\/j.neurot.2026.e00904_bib27","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1002\/anie.202000451","article-title":"Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic","volume":"60","author":"Trist","year":"2021","journal-title":"Angew Chem Int Ed"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00904_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2003.028324","article-title":"Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect","volume":"75","author":"Niemann","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00904_bib29","doi-asserted-by":"crossref","first-page":"1709.e3","DOI":"10.1016\/j.neurobiolaging.2012.10.027","article-title":"Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene","volume":"34","author":"Tortelli","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00904_bib30","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/pharmaceutics15071803","article-title":"Cannabidiol-loaded nanoparticles based on crosslinked starch: anti-inflammatory activity and improved nose-to-brain delivery","volume":"15","author":"Eydelman","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00904_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.neurot.2026.e00904_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fncel.2013.00253","article-title":"An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis","volume":"7","author":"Rotunno","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00904_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"issue":"50","key":"10.1016\/j.neurot.2026.e00904_bib34","doi-asserted-by":"crossref","first-page":"21394","DOI":"10.1073\/pnas.1015463107","article-title":"Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis","volume":"107","author":"Auclair","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002462","article-title":"Evaluating protein cross-linking as a therapeutic strategy to stabilize SOD1 variants in a mouse model of familial ALS","volume":"22","author":"Hossain","year":"2024","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib36","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-018-04114-x","article-title":"The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation","volume":"9","author":"Capper","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2026.e00904_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102980","article-title":"Novel selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis","volume":"59","author":"Amporndanai","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00904_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62903-5","article-title":"Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement","volume":"14","author":"Watanabe","year":"2024","journal-title":"Sci Rep"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:23:51Z","timestamp":1780777431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1878747926000747"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00904","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of a SOD1-stabilizing small molecule ameliorates pathology in an ALS mouse model","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00904"}}